Profitable failure: antidepressant drugs and the triumph of flawed experiments
Drawing on an analysis of Irving Kirsch and colleagues’ controversial 2008 article in PLoS [Public Library of Science] Medicine on the efficacy of SSRI antidepressant drugs such as Prozac, I examine flaws within the methodologies of randomized controlled trials (RCTs) that have made it difficult f...
Autor Principal: | McGoey, L |
---|---|
Formato: | Journal article |
Publicado: |
SAGE Publications
2010
|
Títulos similares
-
Methodological mimesis and the value of pharmaceutical failures
por: McGoey, L
Publicado: (2009) -
Experimental dissidence: economies of credibility in drug regulation
por: McGoey, L
Publicado: (2010) -
Seroxat and the suppression of clinical trial data: regulatory failure and the uses of legal ambiguity
por: McGoey, L, et al.
Publicado: (2008) -
The windfalls after the storm
por: McGoey, L
Publicado: (2007) -
The Politics of Personalised Medicine: Pharmacogenetics in the Clinic By Adam Hedgecoe
por: McGoey, L
Publicado: (2007)